First Time Loading...

Multiplan Corp
NYSE:MPLN

Watchlist Manager
Multiplan Corp Logo
Multiplan Corp
NYSE:MPLN
Watchlist
Price: 0.6543 USD -1.71% Market Closed
Updated: May 6, 2024
Section:
 

Relative Value

The Relative Value of one MPLN stock under the Base Case scenario is 7.6534 USD. Compared to the current market price of 0.6543 USD, Multiplan Corp is Undervalued by 91%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MPLN Relative Value
Base Case
7.6534 USD
Undervaluation 91%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

0.4
P/S
P/S
Price to Sales
0.4
vs History
78
vs Industry
81
Median 3Y
1.5
Median 5Y
1.2
Industry
2.4
Forward
0.4
More Details
Negative
P/E
P/E
Price to Earnings
N/A
vs History
vs Industry
Median 3Y
-1.5
Median 5Y
-4.7
Industry
23.4
Forward
-3.3
More Details
2.5
P/OCF
P/OCF
Price to OCF
2.5
vs History
72
vs Industry
51
Median 3Y
6.1
Median 5Y
5.4
Industry
15.5
More Details
Negative
P/FCFE
P/FCFE
Price to FCFE
N/A
vs History
vs Industry
6
Median 3Y
-1.9
Median 5Y
-3.3
Industry
23.2
More Details
0.2
P/B
P/B
Price to Book Value
0.2
vs History
94
vs Industry
81
Median 3Y
0.8
Median 5Y
1
Industry
2.3
More Details
5.1
EV/S
EV/S
Enterprise Value to Sales
5.1
vs History
60
vs Industry
24
Median 3Y
5.6
Median 5Y
5.4
Industry
2.5
Forward
4.7
More Details
6.7
EV/GP
EV/GP
Enterprise Value to Gross Profit
6.7
vs History
60
vs Industry
35
Median 3Y
7.6
Median 5Y
7.4
Industry
5.3
More Details
8.3
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
8.3
vs History
58
vs Industry
38
Median 3Y
9.1
Median 5Y
8.8
Industry
12.6
Forward
7.5
More Details
28.7
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
28.7
vs History
21
vs Industry
15
Median 3Y
18.4
Median 5Y
17.2
Industry
17.2
Forward
25.5
More Details
28.4
EV/OCF
EV/OCF
Enterprise Value to OCF
28.4
vs History
13
vs Industry
15
Median 3Y
20.7
Median 5Y
18.6
Industry
15.3
More Details
77.7
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
77.7
vs History
11
vs Industry
5
Median 3Y
27.9
Median 5Y
23.5
Industry
19.8
More Details
0.7
EV/IC
EV/IC
Enterprise Value to IC
0.7
vs History
90
vs Industry
69
Median 3Y
0.8
Median 5Y
0.9
Industry
2
More Details

Multiples Across Competitors

MPLN Competitors Multiples
Multiplan Corp Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
US
Multiplan Corp
NYSE:MPLN
424.2m USD 0.4 -4.6 8.3 28.7
US
Veeva Systems Inc
NYSE:VEEV
32.8B USD 13.9 62.4 62.3 67
US
Cerner Corp
NASDAQ:CERN
27.9B USD 4.8 47.3 19.6 38.6
US
Change Healthcare Inc
NASDAQ:CHNG
9B USD 2.6 -116.8 16.5 111.6
AU
Pro Medicus Ltd
ASX:PME
11.9B AUD 81.1 170.1 117 117
US
Inspire Medical Systems Inc
NYSE:INSP
7.4B USD 11.8 -349 -184.9 -171.9
JP
M3 Inc
TSE:2413
1.1T JPY 4.8 24.1 12.5 14.1
US
Doximity Inc
NYSE:DOCS
4.5B USD 9.6 32.6 21.8 23.2
SE
Sectra AB
STO:SECT B
42.6B SEK 26 100.4 -66.1 -66.1
US
Evolent Health Inc
NYSE:EVH
3.1B USD 1.6 -21.7 25.6 272.8
US
Certara Inc
NASDAQ:CERT
2.8B USD 7.9 -50.8 46 461.6
P/E Multiple
Earnings Growth
US
Multiplan Corp
NYSE:MPLN
Average P/E: 72.8
Negative Multiple: -4.6 		N/A
US
Veeva Systems Inc
NYSE:VEEV
62.4
139%
US
Cerner Corp
NASDAQ:CERN
47.3
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
Negative Multiple: -116.8 N/A
AU
Pro Medicus Ltd
ASX:PME
170.1
119%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -349 N/A
JP
M3 Inc
TSE:2413
24.1
26%
US
Doximity Inc
NYSE:DOCS
32.6
79%
SE
Sectra AB
STO:SECT B
100.4
56%
US
Evolent Health Inc
NYSE:EVH
Negative Multiple: -21.7 N/A
US
Certara Inc
NASDAQ:CERT
Negative Multiple: -50.8 N/A
EV/EBITDA Multiple
EBITDA Growth
US
Multiplan Corp
NYSE:MPLN
Average EV/EBITDA: 36.6
8.3
29%
US
Veeva Systems Inc
NYSE:VEEV
62.3
211%
US
Cerner Corp
NASDAQ:CERN
19.6
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
16.5
N/A
AU
Pro Medicus Ltd
ASX:PME
117
124%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -184.9 N/A
JP
M3 Inc
TSE:2413
12.5
24%
US
Doximity Inc
NYSE:DOCS
21.8
103%
SE
Sectra AB
STO:SECT B
Negative Multiple: -66.1 N/A
US
Evolent Health Inc
NYSE:EVH
25.6
194%
US
Certara Inc
NASDAQ:CERT
46
143%
EV/EBIT Multiple
EBIT Growth
US
Multiplan Corp
NYSE:MPLN
Average EV/EBIT: 126.1
28.7
66%
US
Veeva Systems Inc
NYSE:VEEV
67
238%
US
Cerner Corp
NASDAQ:CERN
38.6
N/A
US
Change Healthcare Inc
NASDAQ:CHNG
111.6
N/A
AU
Pro Medicus Ltd
ASX:PME
117
110%
US
Inspire Medical Systems Inc
NYSE:INSP
Negative Multiple: -171.9 N/A
JP
M3 Inc
TSE:2413
14.1
N/A
US
Doximity Inc
NYSE:DOCS
23.2
116%
SE
Sectra AB
STO:SECT B
Negative Multiple: -66.1 N/A
US
Evolent Health Inc
NYSE:EVH
272.8
2 086%
US
Certara Inc
NASDAQ:CERT
461.6
2 181%

See Also

Summary
MPLN intrinsic value, competitors valuation, and company profile.
DCF Valuation
MPLN stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MPLN stock valuation using valuation multiples.
Wall Street Estimates
MPLN price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MPLN stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.